- $1.57m
- -$0.16m
- $7.65m
- 39
- 76
- 57
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.4 | ||
| Price to Tang. Book | 0.4 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.22 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -427.04% | ||
| Return on Equity | -1376.68% | ||
| Operating Margin | -240.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 9.13 | 8.76 | 10.13 | 8.27 | 7.65 | 7.2 | 13.93 | -0.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Directors
- James Cullen NEC (79)
- Jeffrey Soinski PRE (59)
- Mark Weinswig CFO (48)
- Himanshu Patel CTO (60)
- Tamara Elias IND (50)
- James McElwee IND (69)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- March 8th, 2007
- Public Since
- January 30th, 2015
- No. of Shareholders
- 128
- No. of Employees
- 68
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 3,309,430
- Address
- 400 Chesapeake Dr, REDWOOD CITY, 94063-4739
- Web
- https://avinger.com/
- Phone
- +1 6503632400
- Contact
- Matt Kreps
- Auditors
- MOSS ADAMS LLP
Upcoming Events for AVGR
Q1 2025 Avinger Inc Earnings Release
Avinger Inc Annual Shareholders Meeting
Q2 2025 Avinger Inc Earnings Release
Similar to AVGR
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Avinger share price?
As of Today at 18:26 UTC, shares in Avinger are trading at $0.47. This share price information is delayed by 15 minutes.
How has the Avinger share price performed this year?
Shares in Avinger last closed at $0.47 and the price had moved by -84.2% over the past 365 days. In terms of relative price strength the Avinger share price has underperformed the S&P500 Index by -86.63% over the past year.
What are the analyst and broker recommendations for Avinger?
The overall consensus recommendation for Avinger is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Avinger dividend yield?
Avinger does not currently pay a dividend.
Does Avinger pay a dividend?
Avinger does not currently pay a dividend.
When does Avinger next pay dividends?
Avinger does not currently pay a dividend.
How do I buy Avinger shares?
To buy shares in Avinger you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Avinger?
As of the previous close price of $0.47, shares in Avinger had a market capitalisation of $1.57m.
Where are Avinger shares listed?
Here are the trading details for Avinger:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AVGR
What kind of share is Avinger?
Based on an overall assessment of its quality, value and momentum Avinger is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Avinger share price forecast for 2025?
The analyst consensus target price for shares in Avinger is $5.00. That is 954.85% above the last closing price of $0.47.
Analysts covering Avinger currently have a consensus Earnings Per Share (EPS) forecast of -$4.69 for the next financial year.
Find out moreWhat is the trend in the Avinger share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avinger. Over the past six months, its share price has underperformed the S&P500 Index by -61.5%.
As of the last closing price of $0.47, shares in Avinger were trading -64.47% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Avinger PE Ratio?
The Avinger PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Avinger?
Avinger's management team is headed by:
- James Cullen - NEC
- Jeffrey Soinski - PRE
- Mark Weinswig - CFO
- Himanshu Patel - CTO
- Tamara Elias - IND
- James McElwee - IND